{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:48:37Z","timestamp":1792460917769,"version":"4.5.0"},"reference-count":148,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","metabolismjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.metabol.2018.12.006","type":"journal-article","created":{"date-parts":[[2018,12,23]],"date-time":"2018-12-23T11:33:55Z","timestamp":1545564835000},"page":"61-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":270,"special_numbering":"C","title":["Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine"],"prefix":"10.1016","volume":"92","author":[{"given":"Katharina","family":"Nimptsch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Konigorski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Pischon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metabol.2018.12.006_bb0005","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","article-title":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19.2 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2018.12.006_bb0010","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/S0140-6736(05)67483-1","article-title":"Obesity","volume":"366","author":"Haslam","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2018.12.006_bb0015","first-page":"39","article-title":"Body fatness, related biomarkers and cancer risk: an epidemiological perspective","volume":"22","author":"Nimptsch","year":"2015","journal-title":"Horm Mol Biol Clin Invest"},{"key":"10.1016\/j.metabol.2018.12.006_bb0020","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900,000 adults: collaborative analyses of 57 prospective studies","volume":"373","author":"Whitlock","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2018.12.006_bb0025","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1155\/2009\/757683","article-title":"Use of obesity biomarkers in cardiovascular epidemiology","volume":"26","author":"Pischon","year":"2009","journal-title":"Dis Markers"},{"key":"10.1016\/j.metabol.2018.12.006_bb0030","series-title":"Report of a WHO consultation","first-page":"1","article-title":"Obesity: preventing and managing the global epidemic","volume":"894","author":"World Health Organization","year":"2000"},{"key":"10.1016\/j.metabol.2018.12.006_bb0035","series-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults - the evidence report - NIH PUBLICATION NO. 98-4083","author":"Expert Panel on the Identification, Evaluation, and Treatment of Overweight and Obesity in Adults","year":"1998"},{"key":"10.1016\/j.metabol.2018.12.006_bb0040","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1038\/ijo.2010.5","article-title":"Diagnostic performance of body mass index to identify obesity as defined by body adiposity: a systematic review and meta-analysis","volume":"34","author":"Okorodudu","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2018.12.006_bb0045","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(02)09512-0","article-title":"WHO reassesses appropriate body-mass index for Asian populations","volume":"360","author":"Choo","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2018.12.006_bb0050","first-page":"370","article-title":"How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations","volume":"17","author":"Pan","year":"2008","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/j.metabol.2018.12.006_bb0055","series-title":"World Health Organisation: obesity and overweight. Fact Sheet N\u00b0311","author":"World Health Organisation","year":"2015"},{"key":"10.1016\/j.metabol.2018.12.006_bb0060","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.mce.2009.08.018","article-title":"Adipose tissue as an endocrine organ","volume":"316","author":"Galic","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0065","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.diabres.2018.08.005","article-title":"Anthropometric indices as surrogates for estimating abdominal visceral and subcutaneous adipose tissue: a meta-analysis with 16,129 participants","volume":"143","author":"Ping","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/j.metabol.2018.12.006_bb0070","first-page":"470","article-title":"Body mass index, waist circumference, and the risk of type 2 diabetes mellitus","volume":"107","author":"Feller","year":"2010","journal-title":"Dtsch Arztebl Int"},{"key":"10.1016\/j.metabol.2018.12.006_bb0075","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","article-title":"General and abdominal adiposity and risk of death in Europe","volume":"359","author":"Pischon","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.12.006_bb0080","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1002\/oby.20205","article-title":"Measurements of total and regional body composition in preschool children: a comparison of MRI, DXA, and anthropometric data","volume":"21","author":"Karlsson","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2018.12.006_bb0085","doi-asserted-by":"crossref","first-page":"2063","DOI":"10.1002\/oby.20448","article-title":"Changes in fat and skeletal muscle with exercise training in obese adolescents: comparison of whole-body MRI and dual energy X-ray absorptiometry","volume":"21","author":"Lee","year":"2013","journal-title":"Obesity (Silver Spring)"},{"issue":"Suppl. 1","key":"10.1016\/j.metabol.2018.12.006_bb0090","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1007\/s00592-003-0025-y","article-title":"Advances in the application of imaging methods in applied and clinical physiology","volume":"40","author":"Ross","year":"2003","journal-title":"Acta Diabetol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0095","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0091586","article-title":"Validation of anthropometric indices of adiposity against whole-body magnetic resonance imaging\u2014a study within the German European Prospective Investigation into Cancer and Nutrition (EPIC) cohorts","volume":"9","author":"Neamat-Allah","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.12.006_bb0100","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1002\/jmri.23775","article-title":"Automatic quantification of subcutaneous and visceral adipose tissue from whole-body magnetic resonance images suitable for large cohort studies","volume":"36","author":"Wald","year":"2012","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/j.metabol.2018.12.006_bb0105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Davey Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0110","article-title":"The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.12.006_bb0115","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1016\/S0140-6736(11)60105-0","article-title":"Separate and combined associations of body-mass index and abdominal adiposity with cardiovascular disease: collaborative analysis of 58 prospective studies","volume":"377","author":"Emerging Risk Factors C","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2018.12.006_bb0120","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1001\/jamacardio.2016.5804","article-title":"Association of body mass index with cardiometabolic disease in the UK biobank: a Mendelian randomization study","volume":"2","author":"Lyall","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0125","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1161\/CIRCULATIONAHA.116.026560","article-title":"Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a Mendelian randomization analysis","volume":"135","author":"Dale","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2018.12.006_bb0130","author":"Research WCRFAIfC"},{"key":"10.1016\/j.metabol.2018.12.006_bb0135","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1038\/bjc.2017.106","article-title":"Comparison of general obesity and measures of body fat distribution in older adults in relation to cancer risk: meta-analysis of individual participant data of seven prospective cohorts in Europe","volume":"116","author":"Freisling","year":"2017","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2018.12.006_bb0140","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1093\/jnci\/djj246","article-title":"Body size and risk of colon and rectal cancer in the European Prospective Investigation Into Cancer and Nutrition (EPIC)","volume":"98","author":"Pischon","year":"2006","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2018.12.006_bb0145","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.canep.2011.03.001","article-title":"Obesity, metabolic syndrome and esophageal adenocarcinoma: epidemiology, etiology and new targets","volume":"35","author":"Ryan","year":"2011","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0150","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/bjc.2016.188","article-title":"Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer","volume":"115","author":"Jarvis","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2018.12.006_bb0155","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/1055-9965.EPI-14-1309","article-title":"Mendelian randomization study of body mass index and colorectal cancer risk","volume":"24","author":"Thrift","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.metabol.2018.12.006_bb0160","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx012","article-title":"The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: a Mendelian randomization study","volume":"109","author":"Carreras-Torres","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.metabol.2018.12.006_bb0165","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1158\/1055-9965.EPI-16-0147","article-title":"Genetic risk score Mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancer","volume":"25","author":"Painter","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.metabol.2018.12.006_bb0170","first-page":"1603","article-title":"The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium","volume":"26","author":"Davies","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2018.12.006_bb0175","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/j.mcna.2011.06.002","article-title":"Insulin resistance: the link between obesity and cardiovascular disease","volume":"95","author":"Reaven","year":"2011","journal-title":"Med Clin North Am"},{"key":"10.1016\/j.metabol.2018.12.006_bb0180","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1079\/PNS200070","article-title":"Energy balance and cancer: the role of insulin and insulin-like growth factor-I","volume":"60","author":"Kaaks","year":"2001","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/j.metabol.2018.12.006_bb0185","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/nm.4350","article-title":"Insulin action and resistance in obesity and type 2 diabetes","volume":"23","author":"Czech","year":"2017","journal-title":"Nat Med"},{"key":"10.1016\/j.metabol.2018.12.006_bb0190","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.12.006_bb0195","first-page":"147","article-title":"Insulin, IGF-1 and longevity","volume":"1","author":"van Heemst","year":"2010","journal-title":"Aging Dis"},{"key":"10.1016\/j.metabol.2018.12.006_bb0200","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S1470-2045(02)00731-3","article-title":"Insulin-like growth factors and cancer","volume":"3","author":"F\u00fcrstenberger","year":"2002","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0205","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1038\/bjc.1992.65","article-title":"Insulin-like growth factors and cancer","volume":"65","author":"Macaulay","year":"1992","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2018.12.006_bb0210","doi-asserted-by":"crossref","first-page":"3109S","DOI":"10.1093\/jn\/131.11.3109S","article-title":"Insulin, insulin-like growth factors and colon cancer: a review of the evidence","volume":"131","author":"Giovannucci","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/j.metabol.2018.12.006_bb0215","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1023\/A:1006154108619","article-title":"Insulin-like growth factors and prostate cancer","volume":"17","author":"Pollak","year":"1998","journal-title":"Cancer Metastasis Rev"},{"key":"10.1016\/j.metabol.2018.12.006_bb0220","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1146\/annurev.med.080708.082713","article-title":"Biological mechanisms linking obesity and cancer risk: new perspectives","volume":"61","author":"Roberts","year":"2010","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.metabol.2018.12.006_bb0225","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ghir.2005.05.002","article-title":"Rh\/IGF-I\/rhIGFBP-3 administration to patients with type 2 diabetes mellitus reduces insulin requirements while also lowering fasting glucose","volume":"15","author":"Clemmons","year":"2005","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/j.metabol.2018.12.006_bb0230","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1159\/000360571","article-title":"Interaction between insulin-like growth factor-1 and atherosclerosis and vascular aging","volume":"43","author":"Higashi","year":"2014","journal-title":"Front Horm Res"},{"key":"10.1016\/j.metabol.2018.12.006_bb0235","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/ijc.28368","article-title":"Adiposity, mediating biomarkers and risk of colon cancer in the European prospective investigation into cancer and nutrition study","volume":"134","author":"Aleksandrova","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2018.12.006_bb0245","first-page":"65","article-title":"Lifestyle determinants of serum insulin-like growth-factor-I (IGF-I), C-peptide and hormone binding protein levels in British women","volume":"14","author":"Allen","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2018.12.006_bb0250","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1158\/1055-9965.1444.13.9","article-title":"Dietary and lifestyle correlates of plasma insulin-like growth factor-I (IGF-I) and IGF binding protein-3 (IGFBP-3): the multiethnic cohort","volume":"13","author":"DeLellis","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/j.metabol.2018.12.006_bb0255","first-page":"509","article-title":"Nonlinear relationship of insulin-like growth factor (IGF)-I and IGF-I\/IGF-binding protein-3 ratio with indices of adiposity and plasma insulin concentrations (Sweden)","volume":"13","author":"Lukanova","year":"2002","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2018.12.006_bb0260","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/j.annepidem.2009.11.008","article-title":"Lifestyle, anthropometric, and obesity-related physiologic determinants of insulin-like growth factor-1 in the Third National Health and Nutrition Examination Survey (1988\u20131994)","volume":"20","author":"Parekh","year":"2010","journal-title":"Ann Epidemiol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0265","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/sj.ijo.0800412","article-title":"Effect of obesity on total and free insulin-like growth factor (IGF)-1, and their relationship to IGF-binding protein (BP)-1, IGFBP-2, IGFBP-3, insulin, and growth hormone","volume":"21","author":"Nam","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/j.metabol.2018.12.006_bb0270","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3945\/ajcn.113.065565","article-title":"Fasting insulin concentrations and incidence of hypertension, stroke, and coronary heart disease: a meta-analysis of prospective cohort studies","volume":"98","author":"Xun","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2018.12.006_bb0275","doi-asserted-by":"crossref","first-page":"E402","DOI":"10.1503\/cmaj.121950","article-title":"Serum C-peptide levels and risk of death among adults without diabetes mellitus","volume":"185","author":"Min","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/j.metabol.2018.12.006_bb0280","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.003152","article-title":"Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults","volume":"1","author":"Patel","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.metabol.2018.12.006_bb0285","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/j.metabol.2018.12.006_bb0290","doi-asserted-by":"crossref","first-page":"2872","DOI":"10.1001\/jama.294.22.2872","article-title":"Insulin, glucose, insulin resistance, and pancreatic cancer in male smokers","volume":"294","author":"Stolzenberg-Solomon","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.metabol.2018.12.006_bb0295","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/sj.bjc.6603826","article-title":"Circulating insulin-like growth factor axis and the risk of pancreatic cancer in four prospective cohorts","volume":"97","author":"Wolpin","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/j.metabol.2018.12.006_bb0300","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1002\/ijc.22697","article-title":"Serum C-peptide, IGFBP-1 and IGFBP-2 and risk of colon and rectal cancers in the European Prospective Investigation into Cancer and Nutrition","volume":"121","author":"Jenab","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2018.12.006_bb0305","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1080\/13813450801954451","article-title":"Hyper-insulinaemia and cancer, meta-analyses of epidemiological studies","volume":"114","author":"Pisani","year":"2008","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/j.metabol.2018.12.006_bb0310","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/ijc.24927","article-title":"Serum levels of IGF-I, IGFBP-3 and colorectal cancer risk: results from the EPIC cohort, plus a meta-analysis of prospective studies","volume":"126","author":"Rinaldi","year":"2010","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2018.12.006_bb0315","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1470-2045(10)70095-4","article-title":"Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies","volume":"11","author":"Key","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0320","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-149-7-200810070-00006","article-title":"Insulin-like growth factors, their binding proteins, and prostate cancer risk: analysis of individual patient data from 12 prospective studies","volume":"149","author":"Roddam","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.metabol.2018.12.006_bb0325","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/ijc.25381","article-title":"Plasma insulin-like growth factor 1 is positively associated with low-grade prostate cancer in the Health Professionals Follow-up Study 1993\u20132004","volume":"128","author":"Nimptsch","year":"2011","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2018.12.006_bb0330","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1016\/S0140-6736(02)08655-5","article-title":"Circulating concentrations of insulin-like growth factor-I and development of glucose intolerance: a prospective observational study","volume":"359","author":"Sandhu","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2018.12.006_bb0335","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.2337\/db11-1488","article-title":"Insulin-like growth factor axis and risk of type 2 diabetes in women","volume":"61","author":"Rajpathak","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.12.006_bb0340","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1093\/aje\/kwv188","article-title":"Insulin-like growth factor 1 and insulin-like growth factor-binding protein 3 in relation to the risk of type 2 diabetes mellitus: results from the EPIC-Potsdam Study","volume":"183","author":"Drogan","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0345","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1210\/jc.2011-1377","article-title":"Meta-analysis and dose-response metaregression: circulating insulin-like growth factor I (IGF-I) and mortality","volume":"96","author":"Burgers","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2018.12.006_bb0350","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.mam.2011.10.011","article-title":"Immunity as a link between obesity and insulin resistance","volume":"33","author":"Kalupahana","year":"2012","journal-title":"Mol Aspects Med"},{"key":"10.1016\/j.metabol.2018.12.006_bb0355","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/nri1937","article-title":"Adipocytokines: mediators linking adipose tissue, inflammation and immunity","volume":"6","author":"Tilg","year":"2006","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0360","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2018.12.006_bb0365","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Emerging Risk Factors C","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/j.metabol.2018.12.006_bb0370","doi-asserted-by":"crossref","first-page":"d548","DOI":"10.1136\/bmj.d548","article-title":"Association between C reactive protein and coronary heart disease: Mendelian randomisation analysis based on individual participant data","volume":"342","author":"Wensley","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2018.12.006_bb0375","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.metabol.2018.12.006_bb0380","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature01322","article-title":"Inflammation and cancer","volume":"420","author":"Coussens","year":"2002","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.12.006_bb0385","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1136\/jech.2006.051292","article-title":"A systematic review of the association between circulating concentrations of C reactive protein and cancer","volume":"61","author":"Heikkila","year":"2007","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.metabol.2018.12.006_bb0390","doi-asserted-by":"crossref","first-page":"2217","DOI":"10.1200\/JCO.2008.19.8440","article-title":"Baseline C-reactive protein is associated with incident cancer and survival in patients with cancer","volume":"27","author":"Allin","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0395","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/ijc.23606","article-title":"C-reactive protein and colorectal cancer risk: a systematic review of prospective studies","volume":"123","author":"Tsilidis","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2018.12.006_bb0400","first-page":"1397","article-title":"C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis","volume":"25","author":"Zhou","year":"2014","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2018.12.006_bb0405","doi-asserted-by":"crossref","first-page":"234","DOI":"10.3945\/ajcn.110.002683","article-title":"Diet-induced weight loss reduces colorectal inflammation: implications for colorectal carcinogenesis","volume":"93","author":"Pendyala","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2018.12.006_bb0410","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1002\/ijc.29086","article-title":"Association of CRP genetic variants with blood concentrations of C-reactive protein and colorectal cancer risk","volume":"136","author":"Nimptsch","year":"2015","journal-title":"Int J Cancer"},{"key":"10.1016\/j.metabol.2018.12.006_bb0415","first-page":"2077","article-title":"Plasma C-reactive protein, genetic risk score, and risk of common cancers in the atherosclerosis risk in communities study","volume":"24","author":"Prizment","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.metabol.2018.12.006_bb0420","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1530\/eje.1.02338","article-title":"Plasma resistin levels correlate with determinants of the metabolic syndrome","volume":"156","author":"Norata","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0425","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.106.647503","article-title":"Circulating adipocyte-fatty acid binding protein levels predict the development of the metabolic syndrome: a 5-year prospective study","volume":"115","author":"Xu","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/j.metabol.2018.12.006_bb0430","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3389\/fendo.2013.00071","article-title":"Adipokines mediate inflammation and insulin resistance","volume":"4","author":"Kwon","year":"2013","journal-title":"Front Endocrinol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0435","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1111\/j.1440-1681.2011.05557.x","article-title":"Emerging clinical and experimental evidence for the role of lipocalin-2 in metabolic syndrome","volume":"39","author":"Jang","year":"2012","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0440","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s12020-012-9698-8","article-title":"Chemerin: a potential endocrine link between obesity and type 2 diabetes","volume":"42","author":"Roman","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/j.metabol.2018.12.006_bb0445","doi-asserted-by":"crossref","first-page":"2442","DOI":"10.2337\/diacare.26.8.2442","article-title":"Adiponectin: more than just another fat cell hormone?","volume":"26","author":"Chandran","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2018.12.006_bb0450","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.2337\/diacare.26.12.3315","article-title":"Plasma adiponectin and endogenous glucose production in humans","volume":"26","author":"Stefan","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2018.12.006_bb0455","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1111\/obr.12027","article-title":"Adiponectin and incident coronary heart disease and stroke. A systematic review and meta-analysis of prospective studies","volume":"14","author":"Kanhai","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/j.metabol.2018.12.006_bb0460","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1161\/CIRCRESAHA.116.308716","article-title":"Role of adiponectin in coronary heart disease risk: a Mendelian randomization study","volume":"119","author":"Borges","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/j.metabol.2018.12.006_bb0465","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/me.2009-0498","article-title":"Adiponectin represses colon cancer cell proliferation via AdipoR1- and -R2-mediated AMPK activation","volume":"24","author":"Kim","year":"2010","journal-title":"Mol Endocrinol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0470","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/carcin\/bgs133","article-title":"Total and high-molecular-weight adiponectin and risk of colorectal cancer: the European Prospective Investigation into Cancer and Nutrition Study","volume":"33","author":"Aleksandrova","year":"2012","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.metabol.2018.12.006_bb0475","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1158\/1940-6207.CAPR-13-0169","article-title":"Plasma adiponectin and soluble leptin receptor and risk of colorectal cancer: a prospective study","volume":"6","author":"Song","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.metabol.2018.12.006_bb0480","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/j.1751-2980.2011.00504.x","article-title":"Meta-analysis: circulating adiponectin levels and risk of colorectal cancer and adenoma","volume":"12","author":"Xu","year":"2011","journal-title":"J Dig Dis"},{"key":"10.1016\/j.metabol.2018.12.006_bb0485","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1007\/s10654-017-0262-y","article-title":"Genetic variation in the ADIPOQ gene, adiponectin concentrations and risk of colorectal cancer: a Mendelian randomization analysis using data from three large cohort studies","volume":"32","author":"Nimptsch","year":"2017","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0490","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1038\/ncpgasthep0743","article-title":"Leptin and colorectal cancer: an undefined link","volume":"4","author":"Slattery","year":"2007","journal-title":"Nat Clin Pract Gastroenterol Hepatol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0495","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/978-3-319-48382-5_16","article-title":"Diet-induced obesity and the mechanism of leptin resistance","volume":"960","author":"Engin","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0500","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.12.006_bb0505","doi-asserted-by":"crossref","first-page":"100","DOI":"10.2174\/157489007780832533","article-title":"Leptin and the cardiovascular system: a review","volume":"2","author":"Ashwin","year":"2007","journal-title":"Recent Pat Cardiovasc Drug Discov"},{"key":"10.1016\/j.metabol.2018.12.006_bb0510","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/jcp.20472","article-title":"Leptin and cancer","volume":"207","author":"Garofalo","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0515","article-title":"Leptin concentration and risk of coronary heart disease and stroke: a systematic review and meta-analysis","volume":"12","author":"Yang","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.12.006_bb0520","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph14040375","article-title":"Leptin receptor gene polymorphism and the risk of cardiovascular disease: a systemic review and meta-analysis","volume":"14","author":"Wu","year":"2017","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/j.metabol.2018.12.006_bb0525","doi-asserted-by":"crossref","first-page":"7941","DOI":"10.3748\/wjg.v20.i24.7941","article-title":"Association between obesity-related adipokines and colorectal cancer: a case-control study and meta-analysis","volume":"20","author":"Joshi","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0530","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S0006-291X(02)02841-3","article-title":"Resistin is expressed in human macrophages and directly regulated by PPAR gamma activators","volume":"300","author":"Patel","year":"2003","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/j.metabol.2018.12.006_bb0535","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1042\/CS20050078","article-title":"Role of resistin in obesity, insulin resistance and type II diabetes","volume":"109","author":"Kusminski","year":"2005","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/j.metabol.2018.12.006_bb0540","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/j.1476-5381.2011.01369.x","article-title":"Resistin: functional roles and therapeutic considerations for cardiovascular disease","volume":"165","author":"Jamaluddin","year":"2012","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0545","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0120419","article-title":"Association between resistin levels and all-cause and cardiovascular mortality: a new study and a systematic review and meta-analysis","volume":"10","author":"Fontana","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.metabol.2018.12.006_bb0550","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/s41598-017-00138-3","article-title":"Serum resistin is causally related to mortality risk in patients with type 2 diabetes: preliminary evidences from genetic data","volume":"7","author":"Fontana","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2018.12.006_bb0555","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.2337\/dc11-1690","article-title":"Plasma fatty acid-binding protein 4, nonesterified fatty acids, and incident diabetes in older adults","volume":"35","author":"Djousse","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/j.metabol.2018.12.006_bb0560","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1093\/eurjhf\/hfs196","article-title":"Fatty acid-binding protein 4 and incident heart failure: the Cardiovascular Health Study","volume":"15","author":"Djousse","year":"2013","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/j.metabol.2018.12.006_bb0565","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1111\/bph.13505","article-title":"Extracellular nicotinamide phosphoribosyltransferase, a new cancer metabokine","volume":"173","author":"Grolla","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0570","doi-asserted-by":"crossref","first-page":"946427","DOI":"10.1155\/2013\/946427","article-title":"Visfatin\/Nampt: an adipokine with cardiovascular impact","volume":"2013","author":"Romacho","year":"2013","journal-title":"Mediators Inflamm"},{"key":"10.1016\/j.metabol.2018.12.006_bb0575","doi-asserted-by":"crossref","first-page":"D896","DOI":"10.1093\/nar\/gkw1133","article-title":"The new NHGRI-EBI catalog of published genome-wide association studies (GWAS catalog)","volume":"45","author":"MacArthur","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.metabol.2018.12.006_bb0580","doi-asserted-by":"crossref","first-page":"g1900","DOI":"10.1136\/bmj.g1900","article-title":"Obesity, genetic risk, and environment","volume":"348","author":"Blakemore","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/j.metabol.2018.12.006_bb0585","doi-asserted-by":"crossref","first-page":"3641","DOI":"10.1093\/hmg\/ddy271","article-title":"Meta-analysis of genome-wide association studies for height and body mass index in approximately 700,000 individuals of European ancestry","volume":"27","author":"Yengo","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/j.metabol.2018.12.006_bb0590","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.12.006_bb0595","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature14132","article-title":"New genetic loci link adipose and insulin biology to body fat distribution","volume":"518","author":"Shungin","year":"2015","journal-title":"Nature"},{"key":"10.1016\/j.metabol.2018.12.006_bb0600","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.1141634","article-title":"A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity","volume":"316","author":"Frayling","year":"2007","journal-title":"Science"},{"key":"10.1016\/j.metabol.2018.12.006_bb0605","doi-asserted-by":"crossref","DOI":"10.1038\/ctg.2016.1","article-title":"Genetic associations of obesity: the fat-mass and obesity-associated (FTO) gene","volume":"7","author":"Ehrlich","year":"2016","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/j.metabol.2018.12.006_bb0610","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.tig.2010.02.006","article-title":"The genetics of obesity: FTO leads the way","volume":"26","author":"Fawcett","year":"2010","journal-title":"Trends Genet"},{"key":"10.1016\/j.metabol.2018.12.006_bb0615","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1093\/carcin\/bgr026","article-title":"FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans","volume":"32","author":"Nock","year":"2011","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.metabol.2018.12.006_bb0620","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1186\/1471-2407-13-337","article-title":"Association between variations in the fat mass and obesity-associated gene and pancreatic cancer risk: a case-control study in Japan","volume":"13","author":"Lin","year":"2013","journal-title":"BMC Cancer"},{"key":"10.1016\/j.metabol.2018.12.006_bb0625","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s11695-016-2072-9","article-title":"A genetic risk score is associated with weight loss following roux-en Y gastric bypass surgery","volume":"26","author":"Bandstein","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/j.metabol.2018.12.006_bb0630","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1016\/j.nut.2015.05.020","article-title":"A single FTO gene variant rs9939609 is associated with body weight evolution in a multiethnic extremely obese population that underwent bariatric surgery","volume":"31","author":"Rodrigues","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/j.metabol.2018.12.006_bb0635","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1007\/s11695-011-0457-3","article-title":"ESR1, FTO, and UCP2 genes interact with bariatric surgery affecting weight loss and glycemic control in severely obese patients","volume":"21","author":"Liou","year":"2011","journal-title":"Obes Surg"},{"key":"10.1016\/j.metabol.2018.12.006_bb0640","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/sj.ijo.0803138","article-title":"A polymorphism in the adiponectin gene influences adiponectin expression levels in visceral fat in obese subjects","volume":"30","author":"Fredriksson","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2018.12.006_bb0645","doi-asserted-by":"crossref","first-page":"2911","DOI":"10.2337\/diabetes.54.10.2911","article-title":"Plasma visfatin concentrations and fat depot-specific mRNA expression in humans","volume":"54","author":"Berndt","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.metabol.2018.12.006_bb0650","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1093\/ajcn\/75.3.468","article-title":"Resting metabolic rate, plasma leptin concentrations, leptin receptor expression, and adipose tissue measured by whole-body magnetic resonance imaging in women with Prader-Willi syndrome","volume":"75","author":"Goldstone","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2018.12.006_bb0655","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1038\/oby.2010.23","article-title":"Downregulation of ADIPOQ and PPARgamma2 gene expression in subcutaneous adipose tissue of obese adolescents with hepatic steatosis","volume":"18","author":"Kursawe","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/j.metabol.2018.12.006_bb0660","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1507\/endocrj.K11E-073","article-title":"Relationship between vaspin gene expression and abdominal fat distribution of Korean women","volume":"58","author":"Lee","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/j.metabol.2018.12.006_bb0665","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1210\/jc.2005-2848","article-title":"Acquired obesity increases CD68 and tumor necrosis factor-alpha and decreases adiponectin gene expression in adipose tissue: a study in monozygotic twins","volume":"91","author":"Pietilainen","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2018.12.006_bb0670","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1210\/jc.2002-021922","article-title":"Circulating concentration of adiponectin and its expression in subcutaneous adipose tissue in patients with highly active antiretroviral therapy-associated lipodystrophy","volume":"88","author":"Sutinen","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.metabol.2018.12.006_bb0675","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/ijo.2017.283","article-title":"Gene expression profiles indicate tissue-specific obesity regulation changes and strong obesity relevant tissues","volume":"42","author":"Hao","year":"2018","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/j.metabol.2018.12.006_bb0680","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1158\/1940-6207.CAPR-12-0212","article-title":"Gene expression changes in adipose tissue with diet- and\/or exercise-induced weight loss","volume":"6","author":"Campbell","year":"2013","journal-title":"Cancer Prev Res (Phila)"},{"key":"10.1016\/j.metabol.2018.12.006_bb0685","doi-asserted-by":"crossref","first-page":"736","DOI":"10.3945\/ajcn.117.156216","article-title":"Transcriptome profiling from adipose tissue during a low-calorie diet reveals predictors of weight and glycemic outcomes in obese, nondiabetic subjects","volume":"106","author":"Armenise","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/j.metabol.2018.12.006_bb0690","doi-asserted-by":"crossref","first-page":"769","DOI":"10.2217\/epi-2016-0182","article-title":"A systematic review of studies of DNA methylation in the context of a weight loss intervention","volume":"9","author":"Aronica","year":"2017","journal-title":"Epigenomics"},{"key":"10.1016\/j.metabol.2018.12.006_bb0695","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1111\/jcmm.12600","article-title":"A proteomic approach to obesity and type 2 diabetes","volume":"19","author":"Lopez-Villar","year":"2015","journal-title":"J Cell Mol Med"},{"key":"10.1016\/j.metabol.2018.12.006_bb0700","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1002\/prca.200800178","article-title":"Proteomics in obesity research","volume":"3","author":"Barcelo-Batllori","year":"2009","journal-title":"Proteomics Clin Appl"},{"key":"10.1016\/j.metabol.2018.12.006_bb0705","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1159\/000365040","article-title":"Metabolomic biomarkers for obesity in humans: a short review","volume":"64","author":"Rauschert","year":"2014","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/j.metabol.2018.12.006_bb0710","doi-asserted-by":"crossref","first-page":"11356","DOI":"10.1038\/s41598-018-29687-x","article-title":"Gut microbiota is associated with obesity and cardiometabolic disease in a population in the midst of westernization","volume":"8","author":"de la Cuesta-Zuluaga","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2018.12.006_bb0715","doi-asserted-by":"crossref","first-page":"9749","DOI":"10.1038\/s41598-018-28126-1","article-title":"A taxonomic signature of obesity in a large study of American adults","volume":"8","author":"Peters","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/j.metabol.2018.12.006_bb0720","doi-asserted-by":"crossref","first-page":"212","DOI":"10.3389\/fgene.2018.00212","article-title":"Microbiome research is becoming the key to better understanding health and nutrition","volume":"9","author":"Hadrich","year":"2018","journal-title":"Front Genet"},{"key":"10.1016\/j.metabol.2018.12.006_bb0725","doi-asserted-by":"crossref","first-page":"1452","DOI":"10.1021\/acs.jproteome.7b00802","article-title":"Obesity-related metabolomic profiles and discrimination of metabolically unhealthy obesity","volume":"17","author":"Bagheri","year":"2018","journal-title":"J Proteome Res"},{"key":"10.1016\/j.metabol.2018.12.006_bb0730","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.cmet.2016.09.018","article-title":"Metabolomics and metabolic diseases: where do we stand?","volume":"25","author":"Newgard","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/j.metabol.2018.12.006_bb0735","doi-asserted-by":"crossref","first-page":"14966","DOI":"10.1039\/C6RA28715H","article-title":"Emerging role and recent applications of metabolomics biomarkers in obesity disease research","volume":"7","author":"Zhang","year":"2017","journal-title":"RSC Adv"},{"key":"10.1016\/j.metabol.2018.12.006_bb0740","doi-asserted-by":"crossref","first-page":"587","DOI":"10.14348\/molcells.2015.0126","article-title":"A metabolomic approach to understanding the metabolic link between obesity and diabetes","volume":"38","author":"Park","year":"2015","journal-title":"Mol Cells"},{"key":"10.1016\/j.metabol.2018.12.006_bb0745","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/db12-0495","article-title":"Identification of serum metabolites associated with risk of type 2 diabetes using a targeted metabolomic approach","volume":"62","author":"Floegel","year":"2013","journal-title":"Diabetes"}],"container-title":["Metabolism"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604951830266X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S002604951830266X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T04:22:49Z","timestamp":1758428569000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S002604951830266X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":148,"alternative-id":["S002604951830266X"],"URL":"https:\/\/doi.org\/10.1016\/j.metabol.2018.12.006","relation":{},"ISSN":["0026-0495"],"issn-type":[{"value":"0026-0495","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis of obesity and use of obesity biomarkers in science and clinical medicine","name":"articletitle","label":"Article Title"},{"value":"Metabolism","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metabol.2018.12.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}